Table 5. Laboratory findings.
| ω-3 (n=38, 51.4%) | Placebo (n=36, 48.6%) | p | |
|---|---|---|---|
| Total cholesterol (mg/dL) | |||
| Baseline | 203.53±42.09 | 183.50±47.21 | 0.059 |
| 12-month | 139.29±28.73 | 145.17±25.99 | 0.364 |
| p | <0.001 | <0.001 | |
| LDL cholesterol (mg/dL) | |||
| Baseline | 127.00±29.42 | 113.80±35.62 | 0.100 |
| 12-month | 86.81±51.77 | 80.77±21.87 | 0.525 |
| p | <0.001 | <0.001 | |
| HDL cholesterol (mg/dL) | |||
| Baseline | 45.82±12.04 | 41.06±13.58 | 0.130 |
| 12-month | 46.31±12.13 | 44.29±12.77 | 0.497 |
| p | <0.001 | 0.202 | |
| Triglyceride cholesterol (mg/dL) | |||
| Baseline | 131 (90.3, 158.8) | 131 (86.5, 194.0) | 0.883 |
| 12-month | 113 (75.8, 150.8) | 129 (94.0, 176.8) | 0.367 |
| p | 0.287 | 0.674 | 0.871 |
Data are shown as mean±standard deviation or median (IQR), as appropriate. LDL: low-density lipoprotein, HDL: high-density lipoprotein